HRP20191465T1 - Otopine koje sadrže polietilen-glikol i elektrolite - Google Patents

Otopine koje sadrže polietilen-glikol i elektrolite Download PDF

Info

Publication number
HRP20191465T1
HRP20191465T1 HRP20191465T HRP20191465T1 HR P20191465 T1 HRP20191465 T1 HR P20191465T1 HR P20191465 T HRP20191465 T HR P20191465T HR P20191465 T1 HRP20191465 T1 HR P20191465T1
Authority
HR
Croatia
Prior art keywords
solution
solution according
preservative
water
sweetener
Prior art date
Application number
Other languages
English (en)
Croatian (hr)
Inventor
Chris Seldon
Dawn Padfield
Frances Morrissey
Original Assignee
Norgine Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norgine Bv filed Critical Norgine Bv
Publication of HRP20191465T1 publication Critical patent/HRP20191465T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
HRP20191465 2009-07-30 2010-07-30 Otopine koje sadrže polietilen-glikol i elektrolite HRP20191465T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0913295.2A GB0913295D0 (en) 2009-07-30 2009-07-30 Improvements in and relating to pharmaceutical compositions
EP10739973.5A EP2459218B1 (en) 2009-07-30 2010-07-30 Solutions comprising polyethylene glycol and electrolytes
PCT/GB2010/001455 WO2011012866A1 (en) 2009-07-30 2010-07-30 Solutions comprising polyethylene glycol and electrolytes

Publications (1)

Publication Number Publication Date
HRP20191465T1 true HRP20191465T1 (hr) 2019-11-15

Family

ID=41067102

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20191465 HRP20191465T1 (hr) 2009-07-30 2010-07-30 Otopine koje sadrže polietilen-glikol i elektrolite

Country Status (32)

Country Link
US (2) US20120135090A1 (enExample)
EP (1) EP2459218B1 (enExample)
JP (1) JP5708943B2 (enExample)
KR (1) KR101868834B1 (enExample)
CN (2) CN103932979B (enExample)
AR (2) AR077347A1 (enExample)
AT (1) AT12341U1 (enExample)
AU (1) AU2010277354B2 (enExample)
BE (1) BE1019753A5 (enExample)
BR (1) BR112012001899B8 (enExample)
CA (1) CA2769247C (enExample)
CY (1) CY1122081T1 (enExample)
DK (1) DK2459218T3 (enExample)
EA (1) EA025112B1 (enExample)
ES (1) ES2388095B1 (enExample)
FR (1) FR2948569B3 (enExample)
GB (3) GB0913295D0 (enExample)
HR (1) HRP20191465T1 (enExample)
HU (1) HUE046705T2 (enExample)
IT (1) IT1402374B1 (enExample)
LT (1) LT2459218T (enExample)
MX (1) MX337114B (enExample)
NL (1) NL2005176C2 (enExample)
NZ (1) NZ597822A (enExample)
PL (1) PL2459218T3 (enExample)
PT (1) PT2459218T (enExample)
RS (1) RS59294B1 (enExample)
SI (1) SI2459218T1 (enExample)
SM (1) SMT201900569T1 (enExample)
TW (1) TWI478716B (enExample)
WO (1) WO2011012866A1 (enExample)
ZA (1) ZA201200661B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201200637D0 (en) 2012-01-13 2012-02-29 Norgine Bv Improvements in and relating to compositions
MX360450B (es) * 2011-01-31 2018-11-01 Norgine Bv Mejoras de y relacionadas con composiciones.
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
CN102600201B (zh) * 2012-02-07 2014-07-16 舒泰神(北京)生物制药股份有限公司 用于通便和清肠的药物组合物及其制备方法
US20140065076A1 (en) * 2012-08-30 2014-03-06 Otsuka Pharmaceutical Co. Ltd. Container with concentrated substance and method of using the same
BR112015005270B1 (pt) 2012-09-11 2022-11-01 Norgine Bv Composição para mistura com água, solução de limpeza de cólon, seus usos e seu kit
EA034234B1 (ru) 2013-03-15 2020-01-20 Брейнтри Лабораторис, Инк. Пероральные фармацевтические таблетированные композиции двойного применения, содержащие сульфат натрия или его комбинацию с другими сульфатными солями, и способы их получения и применения
CN112494511A (zh) * 2020-12-06 2021-03-16 天津康哲医药科技发展有限公司 一种聚乙二醇钠钾口服药物制剂的制备

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6196786A (en) * 1985-08-01 1987-03-05 Braintree Laboratories Inc. Low-sodium laxative and lavage formulation
JP2596764B2 (ja) 1987-11-18 1997-04-02 ルセル森下株式会社 腸管洗浄液剤
US5378470A (en) 1989-07-25 1995-01-03 Henning Berlin Gmbh Rectally administered pharmaceutical preparation
JPH08505609A (ja) 1992-11-24 1996-06-18 ブロック・ドラッグ・カンパニー・インク 胃腸洗浄用薬剤組成物
RU2111741C1 (ru) * 1994-10-27 1998-05-27 Государственный научный центр колопроктологии Министерства здравоохранения и медицинской промышленности Российской Федерации Вещество для общего промывания желудочно-кишечного тракта
US5710183A (en) 1995-07-14 1998-01-20 Halow; George M. Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent
US6162464A (en) 1997-03-31 2000-12-19 Inkine Pharmaceutical, Inc. Non-aqueous colonic purgative formulations
US6071523A (en) 1998-06-03 2000-06-06 Taro Pharmaceuticals Industries, Ltd. Spill resistant pharmaceutical compositions in semi-solid form
US6048901A (en) 1999-04-20 2000-04-11 Braintree Laboratories, Inc. Method of reducing intestinal gas, cramping and anorectal irritation
IL137275A0 (en) 2000-07-12 2001-07-24 Yosefus Azaria Pharmaceutical composition for the treatment of anal fissures
AU2002335900A1 (en) 2001-10-29 2003-05-12 Shimizu Pharmaceutical Co., Ltd. Bowel cleansing agent
US6946149B2 (en) 2002-04-30 2005-09-20 Braintree Laboratories, Inc. Salt solution for colon cleansing
US7291324B2 (en) * 2002-10-22 2007-11-06 Braintree Laboratories Inc. Method of bowel cleansing
GB0224909D0 (en) * 2002-10-25 2002-12-04 Norgine Europe Bv Colon cleansing compositions
US7332184B2 (en) 2003-03-28 2008-02-19 Queen's University At Kingston Colonic cleansing composition and method
WO2005007170A1 (en) 2003-07-09 2005-01-27 Braintree Laboratories, Inc. Method for treating irritable bowel syndrome using laxatives
WO2005049049A1 (en) * 2003-11-17 2005-06-02 Braintree Laboratories, Inc. Therapeutic peg solution concentrate
GB0409104D0 (en) 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
AU2006244112B2 (en) * 2005-05-06 2011-02-17 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
US20070082061A1 (en) * 2005-10-07 2007-04-12 Nelson Ayala Reduction of saltiness with sweeteners
DE102006001199A1 (de) 2006-01-10 2007-07-12 Medicoforum Gmbh Fixe Kombination von Substanzen unter Beigabe von Entschäumern zum Einsatz als Darmspüllösung und/oder Laxans
ES2278537B1 (es) 2006-01-30 2008-09-16 Laboratorios Casen-Fleet, S.L. Procedimiento de fabricacion de una solucion a base de polietilenglicol con electrolitos, producto obtenido y uso.
CN1850112B (zh) * 2006-03-06 2011-06-29 北京圣永制药有限公司 聚乙二醇-电解质口服溶液
DE112008002398A5 (de) * 2007-09-22 2010-07-29 Bayer Consumer Care Ag Zusammensetzung mit Wirkstoffkombination aus einem Laxans und einem Entschäumer zur Behandlung von Obstipation
US8362083B2 (en) * 2008-01-15 2013-01-29 C.B. Fleet Company Inc. Taste-masked docusate compositions

Also Published As

Publication number Publication date
BR112012001899B1 (pt) 2021-05-04
WO2011012866A1 (en) 2011-02-03
ITMI20101436A1 (it) 2011-01-31
US20120135090A1 (en) 2012-05-31
FR2948569A3 (fr) 2011-02-04
KR20120081584A (ko) 2012-07-19
ES2388095A1 (es) 2012-10-08
EA201200220A1 (ru) 2012-06-29
AU2010277354B2 (en) 2016-02-11
GB2478076A (en) 2011-08-24
GB2472324C (en) 2012-03-07
US20140147518A1 (en) 2014-05-29
CN103932979B (zh) 2019-06-14
KR101868834B1 (ko) 2018-06-19
CN103932979A (zh) 2014-07-23
TWI478716B (zh) 2015-04-01
AR077347A1 (es) 2011-08-17
US9468686B2 (en) 2016-10-18
CA2769247A1 (en) 2011-02-03
GB2478076B (en) 2012-06-06
JP5708943B2 (ja) 2015-04-30
FR2948569B3 (fr) 2012-01-13
ZA201200661B (en) 2012-10-31
EP2459218B1 (en) 2019-07-17
JP2013500322A (ja) 2013-01-07
SI2459218T1 (sl) 2019-10-30
CN102548580A (zh) 2012-07-04
EA025112B1 (ru) 2016-11-30
MX2012001108A (es) 2012-06-01
AU2010277354A1 (en) 2012-02-16
SMT201900569T1 (it) 2019-11-13
IT1402374B1 (it) 2013-09-04
HK1150430A1 (en) 2011-12-30
BR112012001899B8 (pt) 2021-05-25
AR117718A2 (es) 2021-08-25
CY1122081T1 (el) 2020-11-25
ES2388095A8 (es) 2013-07-01
AT12341U1 (de) 2012-04-15
PT2459218T (pt) 2019-09-27
RS59294B1 (sr) 2019-10-31
TW201109021A (en) 2011-03-16
EP2459218A1 (en) 2012-06-06
HUE046705T2 (hu) 2020-03-30
PL2459218T3 (pl) 2020-03-31
DK2459218T3 (da) 2019-10-21
NZ597822A (en) 2013-08-30
MX337114B (es) 2016-02-12
NL2005176C2 (en) 2011-05-17
BR112012001899A2 (pt) 2016-03-15
GB2472324A (en) 2011-02-02
CA2769247C (en) 2017-10-31
GB201108383D0 (en) 2011-06-29
GB201012903D0 (en) 2010-09-15
LT2459218T (lt) 2019-09-25
BE1019753A5 (fr) 2012-12-04
NL2005176A (en) 2011-01-31
GB2472324B (en) 2011-10-05
GB0913295D0 (en) 2009-09-02
ES2388095B1 (es) 2014-02-05
GB2472324A8 (en) 2011-02-23

Similar Documents

Publication Publication Date Title
RU2016147566A (ru) Емкости и способы выдачи доз жидкого концентрата, и жидкие концентраты длительного хранения
JP2016188109A5 (ja) 香味付け飲料濃縮液
JP3766670B2 (ja) 容器詰飲料
HRP20191007T1 (hr) Pripravci koji sadrže peg i askorbat
JP2015527385A5 (enExample)
WO2005117911A3 (en) Taste-masked formulations containing sertraline and sulfoalkyl ether cyclodextrin
UA103906C2 (ru) Жидкая фармацевтическая композиция, которая содержит парацетамол
RU2008147147A (ru) Композиция газированного напитка, содержащего сок и антиоксиданты
WO2007131088A3 (en) Oral rehydration compositions
JP2013500322A5 (enExample)
WO2008139725A1 (ja) 還元飲料用濃縮組成物
MX337114B (es) Soluciones que comprenden polietilenglicol y electrolitos.
WO2007005633A3 (en) Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
RU2015102575A (ru) Жидкие композиции рацекадотрила
EP2534965A3 (en) Use of novel carbohydrates and carbohydrate blends to provide a sports beverage with increased absorption
MY181282A (en) Solutions for increasing the stability and shelf life of an organ and tissue preservation solution
RU2018119685A (ru) Жидкий концентрат напитка с растворимыми волокнами и способ доставки растворимого волокна
JP2013094125A (ja) 果汁入りスポーツ飲料
RU2016130051A (ru) Жидкие композиции рацекадотрила
HRP20220691T1 (hr) Poboljšanja u i u vezi s pripravcima
HRP20130196T1 (hr) Šumeä†e tablete i šumeä†e granule koje sadrže karnitin tartarat
JP2018014978A (ja) ミネラル分としてマグネシウム及びカルシウムを含んだ清涼飲料水
FI3644967T3 (fi) Stabiili vesipitoinen hydroksikarbamidiliuos
JP2014504628A5 (enExample)
JP4571559B2 (ja) 容器詰飲料